Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 403

1.

Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.

Beard GS, Bridger JM, Kill IR, Tree DR.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1389-92. doi: 10.1042/BST0361389.

PMID:
19021561
2.
3.

Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.

Yang SH, Qiao X, Farber E, Chang SY, Fong LG, Young SG.

J Biol Chem. 2008 Mar 14;283(11):7094-9. doi: 10.1074/jbc.M708138200. Epub 2008 Jan 4.

4.

Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.

Rivera-Torres J, Acín-Perez R, Cabezas-Sánchez P, Osorio FG, Gonzalez-Gómez C, Megias D, Cámara C, López-Otín C, Enríquez JA, Luque-García JL, Andrés V.

J Proteomics. 2013 Oct 8;91:466-77. doi: 10.1016/j.jprot.2013.08.008. Epub 2013 Aug 20.

PMID:
23969228
5.

The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.

Delbarre E, Tramier M, Coppey-Moisan M, Gaillard C, Courvalin JC, Buendia B.

Hum Mol Genet. 2006 Apr 1;15(7):1113-22. Epub 2006 Feb 15.

PMID:
16481358
6.

Hutchinson-Gilford progeria syndrome through the lens of transcription.

Prokocimer M, Barkan R, Gruenbaum Y.

Aging Cell. 2013 Aug;12(4):533-43. doi: 10.1111/acel.12070. Epub 2013 Apr 19. Review.

7.

A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.

Gonzalez JM, Pla D, Perez-Sala D, Andres V.

Front Biosci (Schol Ed). 2011 Jun 1;3:1133-46. Review.

PMID:
21622261
8.
9.

Reversible phenotype in a mouse model of Hutchinson-Gilford progeria syndrome.

Sagelius H, Rosengardten Y, Schmidt E, Sonnabend C, Rozell B, Eriksson M.

J Med Genet. 2008 Dec;45(12):794-801. doi: 10.1136/jmg.2008.060772. Epub 2008 Aug 15.

PMID:
18708427
10.

Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.

Chojnowski A, Ong PF, Wong ES, Lim JS, Mutalif RA, Navasankari R, Dutta B, Yang H, Liow YY, Sze SK, Boudier T, Wright GD, Colman A, Burke B, Stewart CL, Dreesen O.

Elife. 2015 Aug 27;4. doi: 10.7554/eLife.07759.

11.

Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.

Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12879-84. Epub 2005 Aug 29.

12.

Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome.

Halaschek-Wiener J, Brooks-Wilson A.

J Gerontol A Biol Sci Med Sci. 2007 Jan;62(1):3-8. Review.

PMID:
17301031
13.

Hutchinson-Gilford progeria syndrome.

Pollex RL, Hegele RA.

Clin Genet. 2004 Nov;66(5):375-81. Review.

PMID:
15479179
14.

Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.

Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS.

Sci Transl Med. 2011 Jun 29;3(89):89ra58. doi: 10.1126/scitranslmed.3002346.

15.

Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.

Han X, Feng X, Rattner JB, Smith H, Bose P, Suzuki K, Soliman MA, Scott MS, Burke BE, Riabowol K.

Nat Cell Biol. 2008 Nov;10(11):1333-40. doi: 10.1038/ncb1792. Epub 2008 Oct 5.

PMID:
18836436
16.

Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.

Arancio W, Pizzolanti G, Genovese SI, Pitrone M, Giordano C.

Gerontology. 2014;60(3):197-203. doi: 10.1159/000357206. Epub 2014 Feb 28. Review.

17.

A conserved splicing mechanism of the LMNA gene controls premature aging.

Lopez-Mejia IC, Vautrot V, De Toledo M, Behm-Ansmant I, Bourgeois CF, Navarro CL, Osorio FG, Freije JM, Stévenin J, De Sandre-Giovannoli A, Lopez-Otin C, Lévy N, Branlant C, Tazi J.

Hum Mol Genet. 2011 Dec 1;20(23):4540-55. doi: 10.1093/hmg/ddr385. Epub 2011 Aug 29.

PMID:
21875900
18.

Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.

Gabriel D, Roedl D, Gordon LB, Djabali K.

Aging Cell. 2015 Feb;14(1):78-91. doi: 10.1111/acel.12300. Epub 2014 Dec 16.

19.

Progeria, the nucleolus and farnesyltransferase inhibitors.

Mehta IS, Bridger JM, Kill IR.

Biochem Soc Trans. 2010 Feb;38(Pt 1):287-91. doi: 10.1042/BST0380287.

PMID:
20074076
20.

Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.

Kreienkamp R, Croke M, Neumann MA, Bedia-Diaz G, Graziano S, Dusso A, Dorsett D, Carlberg C, Gonzalo S.

Oncotarget. 2016 May 24;7(21):30018-31. doi: 10.18632/oncotarget.9065.

Supplemental Content

Support Center